Literature DB >> 1874745

Molecular cloning and analysis of the rat kallikrein-binding protein gene.

K X Chai1, J X Ma, S R Murray, J Chao, L Chao.   

Abstract

The gene encoding rat kallikrein-binding protein (RKBP), a serine protease inhibitor, has been isolated and analyzed with the aid of the polymerase chain reaction. The gene is approximately 10 kilobases in length with four introns of approximately 2.2, 1.8, 0.9, and 0.84 kilobases. This gene is composed of five exons and encodes a polypeptide of 416 amino acid residues. The reactive center region of RKBP is encoded by the fifth exon with the putative P1-P1' residues being Lys-Ser. The organization of the RKBP gene is homologous to those of human alpha 1-antitrypsin and alpha 1-antichymotrypsin in size and arrangement of exons and introns, suggesting that they belong to the same subgroup of serpins. In the 5'-flanking region of the RKBP gene, a variant TATA box sequence, ATAAATA, is found 20 base pairs upstream from the transcription initiation site. The 5'-flanking region of the RKBP gene was able to direct transcription of the reporter gene chloramphenicol acetyltransferase when transfected into a rat hepatoma cell line. An internal promoter-like region was found in the first intron of the RKBP gene, downstream from the transcription initiation site and upstream from the translation initiation codon, however, it was unable to direct expression of the chloramphenicol acetyltransferase reporter gene in our experiments. The expression of RKBP in rat liver was induced by sex hormone treatment as indicated by dot-blot analysis. A genomic Southern blot using an RKBP cDNA probe revealed multiple bands suggesting that the RKBP gene belongs to a family of highly conserved genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1874745

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Kallikrein binding protein (KBP) maps to rat chromosome 6 but does not cosegregate with blood pressure in a GH x BN cross.

Authors:  A Chen; M R Grigor; C M Thompson; E L Harris
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

Review 2.  Protective Role of Kallistatin in Vascular and Organ Injury.

Authors:  Julie Chao; Grant Bledsoe; Lee Chao
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

3.  Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.

Authors:  Ai-Li Shiau; Min-Li Teo; Shin-Yao Chen; Chrong-Reen Wang; Jeng-Long Hsieh; Meng-Ya Chang; Chih-Jui Chang; Julie Chao; Lee Chao; Chao-Liang Wu; Che-Hsin Lee
Journal:  BMC Cancer       Date:  2010-05-31       Impact factor: 4.430

4.  Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.

Authors:  G Gao; C Shao; S X Zhang; A Dudley; J Fant; J-X Ma
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

5.  Expression and characterization of rat kallikrein-binding protein in Escherichia coli.

Authors:  J X Ma; L Chao; G Zhou; J Chao
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

6.  Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.

Authors:  Xiaochen Liu; Zhirong Lin; Tong Zhou; Ronrong Zong; Hui He; Zhen Liu; Jian-xing Ma; Zuguo Liu; Yueping Zhou
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

7.  SERPINA3K plays antioxidant roles in cultured pterygial epithelial cells through regulating ROS system.

Authors:  Chengpeng Zhu; Fangyu Pan; Lianping Ge; Jing Zhou; Longlong Chen; Tong Zhou; Rongrong Zong; Xinye Xiao; Nuo Dong; Maomin Yang; Jian-Xing Ma; Zuguo Liu; Yueping Zhou
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

8.  Elevated Kallikrein-binding protein in diabetes impairs wound healing through inducing macrophage M1 polarization.

Authors:  Juan Feng; Chang Dong; Yanlan Long; Lifang Mai; Meng Ren; Lingyi Li; Ti Zhou; Zhonghan Yang; Jianxing Ma; Li Yan; Xia Yang; Guoquan Gao; Weiwei Qi
Journal:  Cell Commun Signal       Date:  2019-06-10       Impact factor: 5.712

9.  Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review).

Authors:  Qian-Ru Tao; Ying-Ming Chu; Lan Wei; Chao Tu; Yuan-Yuan Han
Journal:  Mol Med Rep       Date:  2021-02-08       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.